Fampridine Pill to Improve Walking for MS Patients Now Available on NHS England

1-Minute Brief

The rollout of fampridine on the NHS offers new treatment options for people with MS struggling with mobility.

Key Facts

• Fampridine is now available on the NHS in England for eligible multiple sclerosis (MS) patients.
• Up to 5,000 people with MS are expected to be eligible for the drug.
• Fampridine works by boosting nerve signals to make walking easier for patients.
• It is the first drug specifically designed to improve walking ability in people with MS.
• MS is an incurable autoimmune disease affecting the brain and spinal cord.

What Happened

The NHS in England has begun offering fampridine, a twice-daily pill, to eligible MS patients to help improve their walking ability.

Why It Matters

This marks the first time a medication targeting walking difficulties in MS patients is available on the NHS, potentially improving quality of life for thousands.

What's Next

Eligible patients can now access the drug through NHS services. Monitoring of patient outcomes and further guidance on eligibility may follow.